Your browser doesn't support javascript.
loading
The role of tumor-associated macrophages in gastric cancer development and their potential as a therapeutic target.
Gambardella, V; Castillo, J; Tarazona, N; Gimeno-Valiente, F; Martínez-Ciarpaglini, C; Cabeza-Segura, M; Roselló, S; Roda, D; Huerta, M; Cervantes, A; Fleitas, T.
Afiliación
  • Gambardella V; Department of Medical Oncology, INCLIVA Biomedical Research Institute, University of Valencia, Valencia, Spain; Instituto de Salud Carlos III, CIBERONC, Madrid, Spain.
  • Castillo J; Department of Biochemistry and Molecular Biology, University of Valencia, Valencia, Spain.
  • Tarazona N; Department of Medical Oncology, INCLIVA Biomedical Research Institute, University of Valencia, Valencia, Spain; Instituto de Salud Carlos III, CIBERONC, Madrid, Spain.
  • Gimeno-Valiente F; Department of Medical Oncology, INCLIVA Biomedical Research Institute, University of Valencia, Valencia, Spain.
  • Martínez-Ciarpaglini C; Instituto de Salud Carlos III, CIBERONC, Madrid, Spain; Department of Pathology, INCLIVA Biomedical Research Institute, Spain.
  • Cabeza-Segura M; Department of Medical Oncology, INCLIVA Biomedical Research Institute, University of Valencia, Valencia, Spain.
  • Roselló S; Department of Medical Oncology, INCLIVA Biomedical Research Institute, University of Valencia, Valencia, Spain; Instituto de Salud Carlos III, CIBERONC, Madrid, Spain.
  • Roda D; Department of Medical Oncology, INCLIVA Biomedical Research Institute, University of Valencia, Valencia, Spain; Instituto de Salud Carlos III, CIBERONC, Madrid, Spain.
  • Huerta M; Department of Medical Oncology, INCLIVA Biomedical Research Institute, University of Valencia, Valencia, Spain.
  • Cervantes A; Department of Medical Oncology, INCLIVA Biomedical Research Institute, University of Valencia, Valencia, Spain; Instituto de Salud Carlos III, CIBERONC, Madrid, Spain.
  • Fleitas T; Department of Medical Oncology, INCLIVA Biomedical Research Institute, University of Valencia, Valencia, Spain; Instituto de Salud Carlos III, CIBERONC, Madrid, Spain. Electronic address: tfleitas@incliva.es.
Cancer Treat Rev ; 86: 102015, 2020 Jun.
Article en En | MEDLINE | ID: mdl-32248000
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias Gástricas / Inhibidores de la Angiogénesis / Antineoplásicos Inmunológicos / Macrófagos Tipo de estudio: Prognostic_studies / Risk_factors_studies Límite: Animals / Humans Idioma: En Revista: Cancer Treat Rev Año: 2020 Tipo del documento: Article País de afiliación: España Pais de publicación: Países Bajos
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias Gástricas / Inhibidores de la Angiogénesis / Antineoplásicos Inmunológicos / Macrófagos Tipo de estudio: Prognostic_studies / Risk_factors_studies Límite: Animals / Humans Idioma: En Revista: Cancer Treat Rev Año: 2020 Tipo del documento: Article País de afiliación: España Pais de publicación: Países Bajos